NEUTREXIN

LOE Approaching

trimetrexate glucuronate

Immune-Onc Therapeutics
NDAINJECTIONINJECTABLEPriority Review
Approved
Dec 1993
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Company
Immune-Onc Therapeutics
Immune-Onc Therapeutics
CA - Palo Alto
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers